Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 1
1950 2
1951 1
1952 1
1954 2
1956 8
1957 1
1958 1
1959 1
1961 1
1962 1
1963 1
1964 5
1965 5
1966 2
1968 3
1969 4
1970 3
1971 4
1972 3
1973 3
1974 2
1975 1
1976 1
1977 1
1978 3
1980 2
1981 3
1982 1
1983 1
1984 3
1985 1
1986 2
1987 1
1988 6
1990 2
1991 4
1992 1
1993 4
1994 7
1995 1
1996 4
1997 12
1998 5
1999 6
2000 8
2001 5
2002 12
2003 5
2004 13
2005 7
2006 10
2007 15
2008 23
2009 20
2010 26
2011 23
2012 38
2013 35
2014 40
2015 42
2016 33
2017 41
2018 31
2019 34
2020 44
2021 52
2022 45
2023 44
2024 17

Text availability

Article attribute

Article type

Publication date

Search Results

722 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.
Heier JS, Khanani AM, Quezada Ruiz C, Basu K, Ferrone PJ, Brittain C, Figueroa MS, Lin H, Holz FG, Patel V, Lai TYY, Silverman D, Regillo C, Swaminathan B, Viola F, Cheung CMG, Wong TY; TENAYA and LUCERNE Investigators. Heier JS, et al. Among authors: figueroa ms. Lancet. 2022 Feb 19;399(10326):729-740. doi: 10.1016/S0140-6736(22)00010-1. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085502 Clinical Trial.
Optical coherence tomography-based consensus definition for lamellar macular hole.
Hubschman JP, Govetto A, Spaide RF, Schumann R, Steel D, Figueroa MS, Sebag J, Gaudric A, Staurenghi G, Haritoglou C, Kadonosono K, Thompson JT, Chang S, Bottoni F, Tadayoni R. Hubschman JP, et al. Among authors: figueroa ms. Br J Ophthalmol. 2020 Dec;104(12):1741-1747. doi: 10.1136/bjophthalmol-2019-315432. Epub 2020 Feb 27. Br J Ophthalmol. 2020. PMID: 32107208 Review.
Reply.
Govetto A, Lalane RA 3rd, Sarraf D, Hubschman JP, Figueroa MS. Govetto A, et al. Among authors: figueroa ms. Am J Ophthalmol. 2017 May;177:227-229. doi: 10.1016/j.ajo.2017.02.005. Epub 2017 Mar 3. Am J Ophthalmol. 2017. PMID: 28262181 No abstract available.
Reply.
Govetto A, Lalane RA 3rd, Sarraf D, Hubschman JP, Figueroa MS. Govetto A, et al. Among authors: figueroa ms. Am J Ophthalmol. 2017 Jul;179:207. doi: 10.1016/j.ajo.2017.04.017. Epub 2017 May 4. Am J Ophthalmol. 2017. PMID: 28478922 No abstract available.
Reply.
Holz FG, Figueroa MS, Bandello F, Yang Y, Ohji M, Dai H, Wykrota H, Sharma S, Dunger-Baldauf C, Lacey S, Macfadden W, Mitchell P; all the LUMINOUS study investigators. Holz FG, et al. Among authors: figueroa ms. Retina. 2020 Sep;40(9):e51-e53. doi: 10.1097/IAE.0000000000002909. Retina. 2020. PMID: 32842092 No abstract available.
Reply.
Figueroa MS, Govetto A, Contreras I, Ruiz-Moreno JM, del Valle FG, Plascencia RN, Medina JL. Figueroa MS, et al. Retina. 2016 Jan;36(1):e4-5. doi: 10.1097/IAE.0000000000000915. Retina. 2016. PMID: 26702607 No abstract available.
Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression.
Cimmino L, Dolgalev I, Wang Y, Yoshimi A, Martin GH, Wang J, Ng V, Xia B, Witkowski MT, Mitchell-Flack M, Grillo I, Bakogianni S, Ndiaye-Lobry D, Martín MT, Guillamot M, Banh RS, Xu M, Figueroa ME, Dickins RA, Abdel-Wahab O, Park CY, Tsirigos A, Neel BG, Aifantis I. Cimmino L, et al. Among authors: figueroa me. Cell. 2017 Sep 7;170(6):1079-1095.e20. doi: 10.1016/j.cell.2017.07.032. Epub 2017 Aug 17. Cell. 2017. PMID: 28823558 Free PMC article.
Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1st International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS).
Bewersdorf JP, Xie Z, Bejar R, Borate U, Boultwood J, Brunner AM, Buckstein R, Carraway HE, Churpek JE, Daver NG, Porta MGD, DeZern AE, Fenaux P, Figueroa ME, Gore SD, Griffiths EA, Halene S, Hasserjian RP, Hourigan CS, Kim TK, Komrokji R, Kuchroo VK, List AF, Loghavi S, Majeti R, Odenike O, Patnaik MM, Platzbecker U, Roboz GJ, Sallman DA, Santini V, Sanz G, Sekeres MA, Stahl M, Starczynowski DT, Steensma DP, Taylor J, Abdel-Wahab O, Xu ML, Savona MR, Wei AH, Zeidan AM. Bewersdorf JP, et al. Among authors: figueroa me. Blood Rev. 2023 Jul;60:101072. doi: 10.1016/j.blre.2023.101072. Epub 2023 Mar 11. Blood Rev. 2023. PMID: 36934059 Review.
Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation.
Moran-Crusio K, Reavie L, Shih A, Abdel-Wahab O, Ndiaye-Lobry D, Lobry C, Figueroa ME, Vasanthakumar A, Patel J, Zhao X, Perna F, Pandey S, Madzo J, Song C, Dai Q, He C, Ibrahim S, Beran M, Zavadil J, Nimer SD, Melnick A, Godley LA, Aifantis I, Levine RL. Moran-Crusio K, et al. Among authors: figueroa me. Cancer Cell. 2011 Jul 12;20(1):11-24. doi: 10.1016/j.ccr.2011.06.001. Epub 2011 Jun 30. Cancer Cell. 2011. PMID: 21723200 Free PMC article.
722 results